Clinical Trials in Philadelphia

Showing 16361-16380 of 20,904 trials

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

NCT01456000

The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrillation by creating electrical isolation of the pulmonary veins.

Paroxysmal Atrial Fibrillation

CardioFocus405 participantsStarted Jan 2012

Birminham, Alabama, United States • Palo Alto, California, United States • Sacramento, California, United States +18 more locations

COMPLETEDPhase 2< 1 mile

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

NCT01286753

This open-label, multi-center study will evaluate the safety and efficacy of Vemurafenib (RO5185426) in participants with metastatic or unresectable papillary thyroid cancer (PTC) positive for the BRAF V600 mutation and resistant to radioactive iodine therapy. Participants will receive vemurafenib 960 milligrams (mg) orally twice daily until progressive disease or unacceptable toxicity occurs.

Neoplasms

Hoffmann-La Roche51 participantsStarted Jun 2011

Torrance, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +13 more locations

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Find Trials by Condition in Philadelphia

Bipolar Study in Adults at Least 18 Years of Age

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

School Breakfast Policy Initiative Study

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism